Portal de Periódicos da CAPES

Preparative Regimens: Chemotherapy versus Chemoradiotherapy

1995; Wiley; Volume: 770; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1995.tb31039.x

1749-6632

George W. Santos,

Oral health in cancer treatment

Annals of the New York Academy of SciencesVolume 770, Issue 1 p. 1-7 Preparative Regimens: Chemotherapy versus Chemoradiotherapy A Historical Perspective GEORGE W. SANTOS, Corresponding Author GEORGE W. SANTOS Professor Emeritus, Johns Hopkins University Baltimore, Marylanda Address for correspondence: George W. Santos, MD, 307B Mariners Point, Hilton Head Plantation, Hilton Head, SC 29926.Search for more papers by this author GEORGE W. SANTOS, Corresponding Author GEORGE W. SANTOS Professor Emeritus, Johns Hopkins University Baltimore, Marylanda Address for correspondence: George W. Santos, MD, 307B Mariners Point, Hilton Head Plantation, Hilton Head, SC 29926.Search for more papers by this author First published: December 1995 https://doi.org/10.1111/j.1749-6632.1995.tb31039.xCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Fabricious-Moeller, J. 1992. Experimental Studies of Hemorrhagic Diathesis from X-ray Sickness. Levin and Munksgaard. Copenhagen . Google Scholar 2 Jacobson, L. O., E. K. Marks, E. O. Gaston & R. E. Zirkle. 1949. Effects of spleen protection on mortality following X-irradiation. J. Lab. Clin. Med. 34: 1538–1543. Web of Science®Google Scholar 3 Jacobson, L. O., E. L. Simmons, E. K. Marks & J. H. Eldredge. 1951. Recovery from radiation injury. Science 113: 510–511. 10.1126/science.113.2940.510 CASPubMedWeb of Science®Google Scholar 4 Lorenz, E., D. E. Uphoff, T. R. Reid & E. Shelton. 1951. Modification of acute irradiation injury in mice and guinea pigs by bone marrow injection. Radiology 58: 863–877. 10.1148/58.6.863 Web of Science®Google Scholar 5 Van Bekkum, D. W. & J. J. De Vries. 1967. Radiation Chimaeras. 1–272. Logas. London . Google Scholar 6 Thomas, E. D., H. L. Lochte, Jr., W. C. Lu & J. W. Ferrebee. 1957. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 257: 491–496. 10.1056/NEJM195709122571102 CASPubMedWeb of Science®Google Scholar 7 Mathé, G., J. L. Amiel, L. Schwarzenberg, A. Cattan & M. Schneider. 1963. Hematopoietic chimera in man after allogeneic (homologous) bone marrow transplantation. Br. Med. J. ii: 1633–1635. 10.1136/bmj.2.5373.1633 Google Scholar 8 Thomas, E. D., C. D. Buckner, M. Banaji, R. A. Clift, A. Fefer, N. Flournoy, B. W. Goodell, R. O. Hickman, K. G. Lerner, P. E. Neiman, G. E. Sale, J. E. Sanders, J. Singer, M. Stevens, R. Storb & P. I. Weiden. 1977. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511–533. 10.1182/blood.V49.4.511.511 CASPubMedWeb of Science®Google Scholar 9 Thomas, E. D., C. D. Buckner, R. A. Clift, A. Fefer, F. L. Johnson, P. E. Neiman, G. E. Sale, J. E. Sanders, J. W. Singer, H. Schulman, R. Storb & P. L. Weiden. 1979. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N. Engl. J. Med. 301: 597–599. 10.1056/NEJM197909133011109 CASPubMedWeb of Science®Google Scholar 10 Santos, G. W. 1991. Bone marrow transplantation: Current studies. In Year Book of Hematology. J. L. Spivak, W. R. Bell, P. M. Ness, P. J. Quesenberry & P. H. Wiernik, Eds.: 181–201. Year Book Medical Publishers, Inc. Chicago , IL . Web of Science®Google Scholar 11 Appelbaum, F. R. & C. D. Buckner. 1986. Overview of the clinical relevance of autologous bone marrow transplantation. Clin, in Haematol. 15: 1–18. 10.1016/S0308-2261(86)80003-0 CASPubMedWeb of Science®Google Scholar 12 Santos, G. W., P. J. Burk, L. L. Sensenbrenner & A. H. Owens, Jr. 1970. Rationale for the use of cyclophosphamide as an immunosuppressant for marrow transplants in man. In Proceedings of the International Symposium on Pharmacological Treatment in Organ and Tissue Transplantation. A. Bertelli & A. P. Monaco, Eds.: 24–31. Exerpta Medica Foundation. Amsterdam . Google Scholar 13 Santos, G. W. 1983. History of bone marrow transplantation. Clin. Haematol. 12: 611–639. 10.1016/S0308-2261(83)80003-4 PubMedWeb of Science®Google Scholar 14 Storb, R., E. D. Thomas, C. D. Buckner, R. A. Clift, F. L. Johnson, A. Fefer, H. Glucksberg, E. R. Giblett, K. G. Lerner & P. Nieman. 1974. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157–180. 10.1182/blood.V43.2.157.157 CASPubMedWeb of Science®Google Scholar 15 Santos, G. W., L. L. Sensenbrenner, P.J. Burke, G. M. Mullins, W. B. Bias, P. J. Tutschka & R. E. Slavin. 1972. The use of cyclophosphamide for clinical transplantation. Transplant. Proc. 4: 559–564. CASPubMedWeb of Science®Google Scholar 16 Hows, J. W., J. C. Marsh, J. L. Yin, S. Durant, D. Swirsky, A. Worsley et al 1989. Bone marrow transplantation for severe aplastic anemia using cyclosporin: Long-term follow-up. Bone Marrow Transplant. 4: 11–16. CASPubMedWeb of Science®Google Scholar 17 Storb, R., G. Longton, C. Anasetti, F. R. Appelbaum, P. Beatty, W. Bensinger et al 1992. Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant. 10: 45–52. Google Scholar 18 Santos, G. W. 1993. The development of busulfan/cyclophosphamide preparative regimens. Semin. Oncol. 20 (suppl. 4): 12–16. CASPubMedWeb of Science®Google Scholar 19 Santos, G. W., P. J. Tutschka, R. Brookmeyer, R. Saral, W. E. Beschorner, W. B. Bias, H. G. Braine, W. H. Burns, G. J. Elfenbein, H. Kaizer, D. Mellits, L. L. Sensenbrenner, R. K. Stuart & A. M. Yeager. 1983. Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide. N. Eng. J. Med. 309: 1347–1353. 10.1056/NEJM198312013092202 PubMedWeb of Science®Google Scholar 20 Grochow, L. B. 1993. Busulfan disposition: The role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin. Oncol. 20 (suppl. 4): 18–25. CASPubMedGoogle Scholar 21 Yeager, A. M., J. E. Wagner, M. L. Graham, G. W. Santos & L. B. Grochow. 1992. Optimization of busulfan dosage in children undergoing bone marrow transplantation: A pharmacokinetic study of dose escalation. Blood 80: 2425–2428. CASPubMedWeb of Science®Google Scholar 22 Tutschka, P. J., E. A. Copelan & J. P. Klein. 1987. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimens. Blood 70: 1382–1388. CASPubMedWeb of Science®Google Scholar 23 Devine, S. M., R. B. Geller, H. K. Holland, J. R. Wingard & R. Saral. 1993. New preparative regimens with diaziquone or cytarabine in combination with busulfan and cyclophosphamide. Semin. Oncol. 20 (suppl. 4): 56–63. CASPubMedWeb of Science®Google Scholar 24 Brodsky, I., J. C. Biggs, J. Szer, P. Crilley, K. Atkinson, K. Downs, A. Dodds, A. J. Concannon, B. R. Avalos, P. Tutschka, N. Kapoor, D. Topolsky, S. I. Bulova & E. A. Copelan. 1993. Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BUCY2): An update. Semin. Oncol. 20 (suppl. 4): 27–31. CASPubMedWeb of Science®Google Scholar 25 Copelan, E. A., J. C. Biggs, J. Szer, J. M. Thompson, P. Crilley, I. Brodsky, J. L. Klein, N. Kapoor, G. S. Harman & B. R. Avalos. 1993. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BUCY2) [Review]. Semin. Oncol. 20 (suppl. 4): 33–38. CASPubMedWeb of Science®Google Scholar 26 Geller, R. B., R. Saral, S. Piantadosi, M. Zahurak, G. B. Vogelsang, J. R. Wingard, R. Ambinder, W. B. Beschorner, H. G. Braine, W. H. Burns, A. D. Hess, R. J. Jones, W. S. May, S. D. Rowley, J. D. Wagner, A. M. Yeager & G. W. Santos. 1989. Allogeneic bone marrow transplantation after high dose busulfan and cyclophosphamide in patients with acute non-lymphocytic leukemia. Blood 73: 2209–2218. CASPubMedWeb of Science®Google Scholar 27 Santos, G. W. Marrow transplantation in acute non-lymphocytic leukemia. Blood 74: 901–908. Google Scholar 28 Clift, R. A., C. D. Buckner, E. D. Thomas, W. I. Bensinger, R. Bowden, E. Bryant, H. J. Deeg, K. C. Doney, L. D. Fisher, J. A. Hansen, P. Martin, G. B. McDonald, J. E. Sanders, G. Schoch, J. Singer, R. Storb, K. M. Sullivan, R. P. Witherspoon & F. R. Applebaum. 1994. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84: 2036–2043. 10.1182/blood.V84.6.2036.2036 CASPubMedWeb of Science®Google Scholar 29 Ringden, O., T. Ruutu, M. Remberger, J. M. Nikoskelainen, J. Volin, L. Vindelev, T. Parkkal, S. Lenhoff, B. Sallerfors, P. Ljungman, L. Mellander & N. Jacobsen for the Nordic bone marrow transplantation group. 1994. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplantation Group. Blood 83: 2723–2730. 10.1182/blood.V83.9.2723.2723 CASPubMedWeb of Science®Google Scholar 30 Blaise, D., D. Maraninchi, E. Archinbaud, J. Reiffers, A. Devergie, J. P. Jouet, N. Milpied, M. Attai, M. Michallet, N. Ifrah, M. Kuentz, C. Dauriac, P. Bordigoni, N. Gratecos, F. Guilhot, D. Guyotat, J. Gouvernet & E. Gluckman for the group d'Etude de la Greffe de Moella Osseuse. 1992. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: A report from the Groupe d'Etudes de la Greffe de Moelle Osseuse. Blood 79: 2578–2582. CASPubMedWeb of Science®Google Scholar 31 Michel, G., E. Gluckman, H. Esperou-Bourdeau, J. Reiffers, J. L. Pico, P. Bordigoni, I. Thuret, D. Blaise, F. Bernaudin, J. P. Jouet, S. Lemerle, H. Rubie, N. Milpied, J. P. Vannier, F. Demeocq, X. Troussard, N. Gratecos, E. Plouvier, C. Bergeron, M. Gardembos, J. Gouvernet & D. Maraninchi. 1994. J. Clin. Oncol. 12: 1217–1222. 10.1200/JCO.1994.12.6.1217 CASPubMedWeb of Science®Google Scholar 32 Blume, K. G., K. J. Kopecky, J. P. Henslee-Downey, S. J. Forman, P. J. Stiff, C. F. LeMaistre & F. R. Appelbaum. 1993. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: A Southwest Oncology Group Study. Blood 81: 2187–2193. 10.1182/blood.V81.8.2187.2187 CASPubMedWeb of Science®Google Scholar 33 Linker, C. A., L. E. Damon, C. A. Ries, H. S. Rugo & J. L. Wolf. 1993. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: An update. Semin. Oncol. 20 (suppl. 4): 40–48. PubMedWeb of Science®Google Scholar 34 Crilley, P., H. Lazarus, D. Topolsky, N. Ciobanu, R. J. Cregor, R. M. Fox, S. I. Bulova, D. C. Shina, R. Gucalp, B. W. Cooper, W. Soegiarso, M. Styler & I. Brodsky. 1993. Comparison of preparative transplant regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies. Semin. Oncol. 20 (suppl. 4): 50–54. CASPubMedWeb of Science®Google Scholar 35 Graw, R. G., R. A. Yankee, G. N. Rogentine, B. G. Leventhal, G. P. Herzig, R. H. Halterman, C. B. Merritt, M. H. McGinniss, G. R. D. Krueger, J. Whong-Peng, P. L. Carolla, D. S. Gullian, M. E. Lippman, H. R. Gralnick, G. W. Berard, P. I. Terasaki & E. S. Henderson. 1972. Bone marrow transplantation from HLA-matched donors to patients with acute leukemia: Toxicity and antileukemic effect. Transplantation 79–90. Google Scholar 36 Appelbaum, F. R. & C. D. Buckner. 1986. Overview of the clinical relevance of autologous bone marrow transplantation. Clin. Haematol. 15: 1–18. 10.1016/S0308-2261(86)80003-0 CASPubMedWeb of Science®Google Scholar 37 Kanfer, E. 1992. Bone marrow transplant conditioning schedules. In Bone Marrow Transplantation in Practice. J. Treleaven & J. Barrett, Eds: 247–255. Churchhill Livingston. Edinburgh , London , Madrid , Melbourne , New York and Tokyo . Google Scholar 38 Chopra, R. & A. Goldstone. 1992. The role of bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma. In Bone Marrow Transplantation. J. Treleaven & J. Barrett, Eds.: 87–104 Churchhill Livingston, Edinburgh , London , Madrid , Melbourne , New York , and Tokyo . Web of Science®Google Scholar Citing Literature Volume770, Issue1Bone Marrow Transplantation: Foundations for the 21st CenturyDecember 1995Pages 1-7 ReferencesRelatedInformation